4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0000905718-17-000737
Director sold 41,312 shares at an average $17.63 ($728,134)
From the SEC's structured data for this filing
Trades in this filing
EMSTER KURT VON · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2017-07-27 | Sale : show line 1 in the form | −40,912 | $17.63 | $721,074 | 2,282,734 | I |
| 2017-07-28 | Sale : show line 2 in the form | −400 | $17.65 | $7,060 | 2,282,334 | I |
| Open-market sales · 41,312 sh · avg $17.63 · $728,134 | ||||||
Loading xslF345X03/vonemster_fm4july272017.xml…